Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S1005 Ph II MK-2206 gastric and GEJ 1/1/2011 5/1/2013 100% Published
    Closed S0000D Adenomatous Colorectal Polyps (ACP) 6/3/2008 5/28/2013 100% Published
    Closed S1108 Phase II MLN8237 in Peripheral T-Cell NHL 10/28/2011 6/6/2013 100% Published
    Closed S1106 Randomized Phase II Younger Patients Mantle Cell Lymphoma 10/1/2011 6/26/2013 29% Published
    Closed S1014 Metastatic PCa Suboptimal Response ADT, Abiraterone Acetate, Ph II 8/9/2011 8/1/2013 98% Published
    Closed S1119 Water Contamination Study 12/2/2011 8/5/2013 100% Published
    Closed S1105 Text Messaging Study 3/27/2012 9/15/2013 100%
    Closed S0806 Phase I/II DLBCL Vorinostat with R-CHOP 11/15/2010 10/1/2013 100% Published
    Closed S0702 CANCER CONTROL: Prospective ONJ Trial 12/15/2008 12/13/2013 100% Published
    Closed S1115 Rando Phase II of AZD-6244 add MK-2206 vs mFOLFOX in Pts with Met Pancreatic Cancer After Chemo 8/15/2012 5/15/2014 100% Published
    Closed S1107 Papillary Renal, ARQ 197 +/- Erlotinib, Ph II 8/20/2012 5/29/2014 71%
    Closed S1008 Physical activity & dietary change weight loss in breast & colorectal survivors Ph II 3/1/2012 7/1/2014 100%
    Closed S0812 Vitamin D for Premenopausal Women at High Risk for Breast Cancer 11/1/2011 8/15/2014 95%
    Closed S0709 Phase II Carboplatin/Paclitaxel/Erlotinib vs Erlotinib Alone in Advanced NSCLC 12/1/2008 9/15/2014 54% Published
    Closed S1117 Rando PII Aza vs. Aza/Len vs. Aza/Vorin for High Risk MDS and CMML 3/1/2012 11/14/2014 100% Published
    Closed S1400E Lung-MAP S1400E: HGF - Rilotumumab plus Erlotinib vs. Erlotinib 6/15/2014 11/25/2014 3%
    Closed S1201 Phase II Rando Trt Based on ERCC1 for Advanced/Met Gastric Ca or Gastroesophageal Junction (GEJ) Ca 2/8/2012 4/1/2015 95%
    Closed S0819 Phase III Carbo/Taxol/Bevacizumab +/- Cetuximab in Advanced NSCLC 7/15/2009 5/1/2015 78% Published
    Closed S1310 Rando PII GSK1120212 vs 5-FU/Leucovorin or Capecitabine for Refractory Advanced Biliary 2/15/2014 5/15/2015 60%
    Closed S0000B SELECT Eye Endpoints (SEE) 7/1/2004 7/31/2015 Published
    Scroll Table